SR-4835

CAT: 0498-bs-83816C-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0498-bs-83816C-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Background
SR-4835 is a potent and selective inhibitor of cyclin-dependent kinases 12 and 13 (KD50s: CDK12 = 98 nM, CDK13 = 4.9 nM) .1 It displayed efficacy against multiple triple-negative breast cancer cell lines (EC50s: MDA-MB-231 15.5 nM; MDA-MB-468 22.1 nM; HS578T 19.9 nM; MDA-MB-436 24.9 nM) . Inhibition of CDK12/13 with SR-4835 resulted in down-regulation of multiple DNA damage response genes and caused increased DNA damage and apoptosis. SR-4835 acted synergistically with DNA-damaging agents and PARP inhibitors to cause triple-negative breast cancer cell death.1,2 It acted synergistically with PD-1 blockade to provide a durable immune-mediated antitumor response in a syngeneic breast cancer mouse model.3 SR-4835 has been found to act as a molecular glue that promotes cyclin K degradation.4 Inhibition of CDK12 with SR-4835 suppressed tumor initiation and growth in a colorectal cancer mouse model and impaired liver metastasis of colorectal cancer cells while also diminishing cancer stem cell traits through ß-catenin pathway activation.5
Conjugation
Unconjugated
Buffer
Off-white solid
Storage Conditions
-20°C

Related Products

CatalogName
bs-82157C-01SR-1001
bs-82284C-01SR-3576
bs-82293C-01SR-9009
bs-82106C-01SR-144528
bs-82288C-01SR-8278
bs-83048C-01SR-717
bs-7124C-01SR-59230A oxalate
bs-102497P-01Recombinant Human CXCL16/SR-PSOX Protein, N-GST
bs-102498P-01Recombinant Human CXCL16/SR-PSOX Protein, N-His
bs-105479P-01Recombinant Human SCARB1/SR-BI/CLA-1/SRB1 Protein, N-His

Alternative Products

CatalogName
MBS3611563-01SR-4835
A22337-100SR-4835 100mg
A22337-25SR-4835 25mg
A22337-500SR-4835 500mg
A22337-2SR-4835 2mg
A22337-50SR-4835 50mg
A22337-1SR-4835 1mg
A22337-5SR-4835 5mg
A22337-10SR-4835 10mg
TL311108VNQO2 Human shRNA Lentiviral Particle (Locus ID 4835)

Popular Products